Literature DB >> 7003315

A placebo-controlled trial of ethinyl oestradiol and norethisterone in climacteric women.

B E Nordin, M M Jones, R G Crilly, D H Marshall, R Brooke.   

Abstract

A placebo-controlled trial has shown that 15 microgram of ethinyl oestradiol is as effective as 25 microgram daily in reducing both menopausal symptoms and the urinary excretion of calcium and hydroxyproline. Norethisterone 5 mg daily also showed a significant reduction in the climacteric symptoms but was less effective than either of the ethinyl oestradiol doses.

Entities:  

Keywords:  Contraception; Contraceptive Agents, Estrogen--administraction and dosage; Contraceptive Agents, Estrogen--therapeutic use; Contraceptive Agents, Female--administraction and dosage; Contraceptive Agents, Female--therapeutic use; Contraceptive Agents, Progestin--administraction and dosage; Contraceptive Agents, Progestin--therapeutic use; Contraceptive Agents--administraction and dosage; Contraceptive Agents--therapeutic use; Double-blind Studies; Ethinyl Estradiol--administraction and dosage; Ethinyl Estradiol--therapeutic use; Family Planning; Menopause; Norethindrone--administraction and dosage; Norethindrone--therapeutic use; Reproduction; Research Methodology; Studies

Mesh:

Substances:

Year:  1980        PMID: 7003315     DOI: 10.1016/0378-5122(80)90009-2

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  2 in total

1.  Dose dependent response of symptoms, pituitary, and bone to transdermal oestrogen in postmenopausal women.

Authors:  M Peacock; P Selby
Journal:  Br Med J (Clin Res Ed)       Date:  1987-02-14

Review 2.  Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes.

Authors:  A H Maclennan; J L Broadbent; S Lester; V Moore
Journal:  Cochrane Database Syst Rev       Date:  2004-10-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.